Tg Therapeutics, Inc.
Tg Therapeutics, Inc.'s email is ir@tgtxinc.com
and
Tg Therapeutics, Inc.'s phone number is (212)554-4484
.
TG Therapeutics is an innovative, clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. Currently, the company is developing two therapies targeting hematological malignancies. TG-1101 (ublituximab) is a novel, glycoengineered, third generation monoclonal antibody that targets a specific and unique epitope on the CD20 antigen found on mature B-lymphocytes. TG Therapeutics is also developing TGR-1202, an orall...
read more
TG Therapeutics is an innovative, clinical-stage biopharmaceutical company focused on the acquisition, development and commercialization of medically important pharmaceutical products for the treatment of cancer and other underserved therapeutic needs. Currently, the company is developing two therapies targeting hematological malignancies. TG-1101 (ublituximab) is a novel, glycoengineered, third generation monoclonal antibody that targets a specific and unique epitope on the CD20 antigen found on mature B-lymphocytes. TG Therapeutics is also developing TGR-1202, an orally available PI3K delta inhibitor. The delta isoform of PI3K is strongly expressed in cells of hematopoietic origin and is believed to be important in the proliferation and survival of B-lymphocytes. Both TG-1101 and TGR-1202 are in clinical development for patients with hematologic malignancies. TG Therapeutics is headquartered in New York City and is traded on NASDAQ under the ticker symbol ''TGTX''.
show less
Website | tgtherapeutics.com | |
Industry | Biotechnology | |
Location | New York, New York, United States | |
Employees | 189 | |
Founded | 2012 |
HQ | 1230 Avenue of the Americas 7th Floor | |
Phone | (212)554-4484 | |
ir@tgtxinc.com | ||
Funding | 205,000,000 USD | |
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
Website | tgtherapeutics.com | |
Industry | Biotechnology | |
Location | New York, New York, United States | |
Employees | 189 | |
Founded | 2012 | |
linkedin.com/company/tg-therapeutics | ||
HQ | 1230 Avenue of the Americas 7th Floor | |
Phone | (212)554-4484 | |
ir@tgtxinc.com | ||
Funding | 205,000,000 USD |
Top Competitors for Tg Therapeutics, Inc.
Tg Therapeutics, Inc. Questions
Where are Tg Therapeutics, Inc.'s headquarters?
Tg Therapeutics, Inc.'s headquarters are in 1230 Avenue of the Americas 7th Floor
What is Tg Therapeutics, Inc.'s phone number?
Tg Therapeutics, Inc.'s phone number is (212)554-4484
What is Tg Therapeutics, Inc.'s official website?
Tg Therapeutics, Inc.'s website is tgtherapeutics.com
How many employees are working in Tg Therapeutics, Inc. right now?
Tg Therapeutics, Inc. has
189 employees.
View the Email and Phone Numbers for all 189 working at Tg Therapeutics, Inc..
What is Tg Therapeutics, Inc.'s industry?
Tg Therapeutics, Inc.'s industry is
Biotechnology
Who are Tg Therapeutics, Inc.'s top competitors?
Tg Therapeutics, Inc.'s top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What is Tg Therapeutics, Inc.'s email address?
Tg Therapeutics, Inc.'s email address is ir@tgtxinc.com
What are Tg Therapeutics, Inc.'s categories?
Tg Therapeutics, Inc.'s categories are Biotechnology, Health Care, Therapeutics
What is Tg Therapeutics, Inc.'s location?
Tg Therapeutics, Inc.'s location is
New York, New York, United States
When was Tg Therapeutics, Inc.'s founded?
Tg Therapeutics, Inc.'s founding year is 2012
What is Tg Therapeutics, Inc.'s funding?
Tg Therapeutics, Inc.'s funding is 205,000,000 USD
What is Tg Therapeutics, Inc.'s current status?
Tg Therapeutics, Inc.'s current status is ipo
Top Tg Therapeutics, Inc. Employees
Director Clinical Operations
jmayer@celgene.com
+1908-673-2070
Hematology Consultant
lisa.lapoint@yahoo.com
+1713-571-7269
Vice President Clinical Operations
rreilly@novellaclinical.com
+1919-484-1921
Director, Market Access Account Management
ejroush@gmail.com
+1614-761-7533
Safety Specialist
lasha.short@wellmont.org
+1423-483-2432
Executive Assistant
olivia.pavis@gs.com
+1718-873-3509
Director, Computer Systems Compliance
jesse.jones@cenduit.com
+1919-998-3860